Ondansetron treatment in a child presenting with chronic intractable pruritus.
The case of a seven-year-old boy with chronic pruritus secondary to a giant congenital melanocytic nevus is presented. The pruritus did not respond to conventional antipruritic drug treatment, but responded to ondansetron, a selective antagonist of 5-hydroxytryptamine type 3 receptors.
Frigon
Chantal
C
Chronic Pain Clinic, Department of Anesthesia, The Montreal Children's Hospital, Montreal, Quebec, Canada. chantal.frigon@muhc.mcgill.ca
Desparmet
Joëlle
J
D000982:Antipruritics / Q000627:therapeutic use*; D002648:Child; D002908:Chronic Disease; D006801:Humans; D008297:Male; D017294:Ondansetron / Q000627:therapeutic use*; D011537:Pruritus / Q000188:drug therapy*
D000982:Antipruritics; D017294:Ondansetron